Acta Veterinaria et Zootechnica Sinica ›› 2025, Vol. 56 ›› Issue (10): 5266-5276.doi: 10.11843/j.issn.0366-6964.2025.10.045

• Clinical Veterinary Medicine • Previous Articles     Next Articles

Forsythiaside A Inhibits Replication of H9N2 Avian Influenza Virus by Modulating the TLR3-NF-κB Signaling Pathway

ZHANG Taiming1(), LI Yaxuan1(), WANG Changshou2, HU Ge1,*()   

  1. 1. Collegeof Animal Science and Technology, Beijing University of Agriculture, Beijing 102206, China
    2. Department of Agronomy, Hetao College, Bayannur 015000, China
  • Received:2024-12-20 Online:2025-10-23 Published:2025-11-01
  • Contact: HU Ge E-mail:18146501316@163.com;yaxuan599@163.com;bnhuge@126.com

Abstract:

This study aimed to investigate the inhibitory effects of Forsythiaside A (FTA) on the replication of H9N2 avian influenza virus (H9N2 AIV) in pulmonary microvascular endothelial cells (PMVECs) and explore its underlying mechanisms. PMVECs infected with H9N2 AIV were treated with varying concentrations of FTA. Cytotoxicity was assessed using the MTT assay, and viral replication was analyzed via RT-qPCR. Protein expression levels of TLR3, TRIF, and NF-κB were evaluated using Western blot, while cytokine secretion (TNF-α, IL-6) and type Ⅰ interferons (IFN-α, IFN-β) were measured through ELISA. The results showed that FTA significantly inhibited the replication of H9N2 AIV (P < 0.05) in a dose-dependent manner. It downregulated the overexpression of TLR3, TRIF, and NF-κB proteins (P < 0.05), suppressed the secretion of pro-inflammatory cytokines (P < 0.05), and enhanced the production of type Ⅰ interferons (P < 0.05). FTA exhibits significant antiviral activity against H9N2 AIV by modulating the TLR3-NF-κB signaling pathway and regulating cytokine expression, highlighting its potential as a novel host-targeted antiviral agent.

Key words: forsythiaside A, H9N2 avian influenza virus, TLR3-NF-κB signaling pathway, cytokines, pulmonary microvascular endothelial cells, antiviral therapy, traditional Chinese medicine

CLC Number: